Navegar por autor "Debén Ariznavarreta, Guillermo"

Mostrando ítems 1-15 de 15

ACUTE MYELOID LEUKEMIA IN PATIENTS 70 AND ABOVE. AZACITIDINE VERSUS INTENSIVE CHEMOTHERAPY

2014- Debén Ariznavarreta, Guillermo; Pérez Encinas, Manuel Mateo
Assessment of minimal residual disease levels in b-cll after front-line treatment with fc-r and rituximab maintenance

2012- Debén Ariznavarreta, Guillermo
Azacitidine as front-line therapy in AML: Results from spanish national registry. Alma study investigators

2012- Debén Ariznavarreta, Guillermo; Pérez Encinas, Manuel Mateo
Azacitidine frontline therapy for unfit acute myeloid leukemia patients: clinical use and outcome prediction

2015- Debén Ariznavarreta, Guillermo; Pérez Encinas, Manuel Mateo
Azacitidine in older patients with acute myeloid leukemia (AML). Results from the ALMA study according to the MRC risk index score

2015- Debén Ariznavarreta, Guillermo; Pérez Encinas, Manuel Mateo
Bendamustine in combination with rituximab as first-line treatment for indolent non-hodgkin lymphoma: Retrospective analysis of An Spanish registry

2013- Debén Ariznavarreta, Guillermo
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program

2015- Debén Ariznavarreta, Guillermo; Fernandez Fernandez, Angeles; Romero Picos , Esperanza; Romo Collada, Mario Andres
Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study)

2013- Debén Ariznavarreta, Guillermo; Bello López, José Luis
CLINICAL OUTCOMES OF ACUTE ERYTHROLEUKEMIA TREATED WITH AZACITIDINE: A RETROSPECTIVE MULTICENTER STUDY

2015- Debén Ariznavarreta, Guillermo
Clofarabine in acute myeloid leukemia. the spanish experience

2011- Debén Ariznavarreta, Guillermo; Sastre Moral, José Luis; Fernandez Fernandez, Angeles; Vilariño López, María Dolores
Enfermedad pulmonar intersticial difusa como primera manifestación demacroglobulinemia de Waldenström: descripción de un caso y revisión de la literatura

2014- Debén Ariznavarreta, Guillermo; Marcos Rodríguez, Pedro Jorge; Verea Hernando, Hector; Pombo Otero, Jorge; Consuegra Vanegas, Angelica; [et al.]
Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients

2014- Debén Ariznavarreta, Guillermo
Long-term outcome of 151 patients with relapsed APL receiving second-line with chemotherapy or arsenic trioxide-based regimens

2013- Debén Ariznavarreta, Guillermo
Retrospective study of azacitidine in patients of advanced age with acute myeloid leukemia (lma). Results of the alma/ pethema cohort in comparison with the mrc risk index score

2015- Debén Ariznavarreta, Guillermo; Pérez Encinas, Manuel Mateo
THE AGE >65 YEARS AND RESPONSE TO THE RECOVERY TREATMENT, PRINCIPAL FACTORS THAT AFFECT THE SURVIVAL OF PATIENTS WITH NON HODGKIN LYMPHOMA IN RELAPSE/ REFRACTORIES, TREATED WITH R-ESHAP AND AUTO-TPH

2015- López Fernández, María Fernanda; Debén Ariznavarreta, Guillermo; Fernandez Lopez, Carlos; Torres Carrete, Juan Pío; Noriega Concepción, Victor; [et al.]